Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Ignyta
Company Monitoring Page for Ignyta
latest headlines for company on cafepharma
Go or no go? Abbvie, Roche and Kala await key decisions
EP Vantage
Fri, 07/26/19 - 11:04 am
Tags:
FDA
,
AbbVie
,
upadacatinib
,
Roche
,
Ignyta
,
entrectinib
,
Kala Pharmaceuticals
,
KPI-121
,
dry eye disease
Joining AI Drug Discovery Race, Erasca Adds $22M For Cancer Work
Xconomy
Fri, 03/8/19 - 09:37 am
Tags:
Erasca
,
Ignyta
,
artificial intelligence
Loxo's targeted therapy holds up to Roche challenge
Biopharma Dive
Sun, 10/21/18 - 11:36 pm
Tags:
Roche
,
entrectinib
,
Loxo Oncology
,
Ignyta
,
Bayer
,
larotrectinib
Another Precision Step for Roche as Ignyta Drug Heads to Regulators
Xconomy
Mon, 09/24/18 - 03:32 pm
Tags:
Roche
,
entrectinib
,
Ignyta
,
FDA
,
non-small cell lung cancer
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Sat, 12/23/17 - 11:39 pm
Tags:
biotech
,
Ignyta
,
Roche
,
M&A
,
Molecular Templates
,
Biohaven Pharmaceuticals
,
trigriluzole
Roche Bets $1.7B More on Precision Oncology With Ignyta Deal
Xconomy
Fri, 12/22/17 - 09:51 am
Tags:
Roche
,
Ignyta
,
M&A
,
precision medicine
,
oncology
Hunting an early FDA OK, Ignyta surges on promising snapshot of lung cancer data
Endpoints
Wed, 10/18/17 - 09:24 am
Tags:
Ignyta
,
entrectinib
,
non-small cell lung cancer
Top-Performing Biotech and Drug Stocks During ASCO '15
TheStreet.com
Fri, 06/5/15 - 07:13 pm
Tags:
ASCO
,
Ignyta
,
Immunogen
,
Puma Biotechnology
,
AbbVie
,
Roche
,
Bristol-Myers Squibb
,
Seattle Genetics
,
Juno Therapeutics
The 4 Overlooked Winners of ASCO
24/7 Wall St
Tue, 06/2/15 - 09:12 am
Tags:
ASCO
,
Bristol-Myers Squibb
,
AbbVie
,
Aveo Pharmaceuticals
,
Ignyta
Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Yahoo/BusinessWire
Sun, 09/28/14 - 09:43 am
Tags:
Ignyta
,
RXDX-101
,
non-small cell lung cancer
Ignyta: Now Public With A Targeted Oncology Pipeline Poised For Success
Seeking Alpha
Mon, 02/24/14 - 09:19 am
Tags:
Ignyta
,
oncology
,
Clovis Oncology
,
Ariad Pharmaceuticals
,
Mirati Therapeutics
,
Tesaro
,
Puma Biotechnology
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.